JHMH:ARCA-John Hancock Multifactor Healthcare

ETF | Health | NYSE Arca

Last Closing Price

USD 32.80

Change

+0.18 (+0.55)%

Market Cap

USD 0.04B

Volume

8.83K

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the John Hancock Dimensional Healthcare Index. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's benchmark index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. Company at the time of reconstitution. The fund is non-diversified.

Inception Date: 29/09/2015

Primary Benchmark: JH Dimensional Healthcare TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 1.23%

Management Expense Ratio: 0.50 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

+0.43 (+0.50%)

USD 17.56B
VHT Vanguard Health Care 0.10 %

+0.25 (+0.15%)

USD 7.51B
XBI SPDR Series Trust S&P Biotech 0.35 %

-2.78 (-3.10%)

USD 4.61B
IYH iShares U.S. Healthcare 0.44 %

+0.62 (+0.34%)

USD 2.04B
IXJ iShares Global Healthcare 0.48 %

+0.06 (+0.05%)

USD 1.70B
IHI iShares U.S. Medical Devices 0.44 %

-0.58 (-0.32%)

USD 1.58B
FBT First Trust Amex Biotech Index.. 0.56 %

-2.94 (-2.22%)

USD 1.28B
FXH First Trust Health Care AlphaD.. 0.62 %

-0.34 (-0.46%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

-0.10 (-0.42%)

USD 0.97B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

+0.09 (+0.21%)

USD 0.97B

ETFs Containing JHMH

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.34% 79% C+ 79% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.34% 79% C+ 79% C+
Trailing 12 Months  
Capital Gain 22.45% 50% F 74% C
Dividend Return 1.16% 46% F 14% F
Total Return 23.61% 54% F 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.11% 36% F 62% D-
Dividend Return 6.61% 25% F 48% F
Total Return 0.50% 32% F 8% F
Risk Return Profile  
Volatility (Standard Deviation) 7.84% 96% A 82% B-
Risk Adjusted Return 84.31% 64% D 70% C-
Market Capitalization 0.02B 14% F 14% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.